Article Details

Zacks: Analysts Anticipate Flexion Therapeutics, Inc. (NASDAQ:FLXN) Will Post Quarterly Sales of ...

Retrieved on: 2020-12-14 08:37:30

Tags for this article:

Click the tags to see associated articles and topics

Zacks: Analysts Anticipate Flexion Therapeutics, Inc. (NASDAQ:FLXN) Will Post Quarterly Sales of .... View article details on hiswai:

Excerpt

<b>Vanguard Group</b> Inc. now owns 2,274,797 shares of the specialty pharmaceutical company's stock valued at $29,913,000 after purchasing an additional ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up